2018-12-07 10:57:10 | Akorn sinks after court upholds decision on Fresenius ending dealShares of Akorn (AKRX) sank after Delaware's top court upheld an earlier ruling that Fresenius (FSNUY) can end its planned $4.3B takeover of the generic drugmaker. The high court agreed that a material adverse change took place since the deal was announced. Shares of Akorn, before halting for volatility, sank 17%, or 95c, to $4.64. |
---|